GD2-CAR-T
/ Royal Adelaide Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Initial clinical and laboratory results of an ongoing dose escalation study of autologous GD2-CAR-T cells in patients with recurrent GD2-positive glioblastoma
(AACR 2026)
- "Abstract is embargoed at this time."
CAR T-Cell Therapy • Clinical • Brain Cancer • Glioblastoma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1